Amgen Manufacturing Ltd – FDA 483, Jul 5, 2023
Amgen Manufacturing Ltd in Juncos, PR, was cited with three observations during an FDA inspection. The firm demonstrated inadequate control procedures for manufacturing processes, specifically regarding alarm management during visual inspection. Additionally, deficiencies were noted in the drug product stability program, including delayed study initiation and insufficient monitoring of contract manufacturing sites. Finally, the facility experienced repeated pest control failures, leading to numerous infestations in critical manufacturing and storage areas.
ID · ceae345a-06d0-4a2c-9f27-1c7016f467b7
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.